Explosion at Chinese pharmaceutical plant leaves 10 dead

仿制药疫苗
Dozens hurt and 10 people dead after an accident during renovation work in Shandong province, China. The company involved, Qilu Tianhe Huishi Pharmaceuticals, had ordered maintenance work to be carried out on underground piping, which subsequently caused an explosion, according to local media reports ​. It was reported that welding of the piping caused a heat-transferring substance to ignite, causing an explosion and resulted in 10 workers dying of smoke inhalation, with a further 12 suffering minor injuries. The local city government of Jinan are investigating the causes of the accident. Qilu Tianhe specialises in the production of generic drugs and active pharmaceutical ingredients, with the company noting on its website that all of its products have passed the Chinese GMP standard. The company involved did not respond to a request for comment. In 2015 ​, a GlaxoSmithKline owned facility suffered an explosion in Tianjin, China. The situation led to the facility’s good manufacturing practice (GMP) certification being revoked by the UK’s regulatory body. More recently, there was a national outcry after vaccines that were administered to children across the country were found to be improperly manufactured or substandard. The case led to a number of officials being dismissed ​.
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。